Icares Medicus Inc (6612) — Capital Reinvestment Ratio
Icares Medicus Inc (6612) has a Capital Reinvestment Ratio of 0.19x as of June 2025, meaning it reinvests 0% of its operating cash flow (NT$105.58 Million) in capital expenditures (NT$20.18 Million). Check 6612 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Icares Medicus Inc Capital Reinvestment Ratio (2017–2022)
This chart tracks Icares Medicus Inc's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see 6612 cash flow conversion.
Annual Capital Reinvestment Ratio for Icares Medicus Inc (2017–2022)
Year-by-year Capital Reinvestment Ratio for Icares Medicus Inc from 2017 to 2022. See Icares Medicus Inc (6612) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.26x | NT$128.92 Million | NT$34.03 Million | ▲ +57.2% |
| 2021 | 0.17x | NT$38.57 Million | NT$6.48 Million | ▲ +7.0% |
| 2020 | 0.16x | NT$71.37 Million | NT$11.20 Million | ▼ -85.1% |
| 2019 | 1.05x | NT$88.78 Million | NT$93.41 Million | ▲ +995.0% |
| 2018 | 0.10x | NT$63.22 Million | NT$6.08 Million | ▼ -48.3% |
| 2017 | 0.19x | NT$45.47 Million | NT$8.44 Million | — |